Newsletter | March 26, 2025

03.26.25 -- CDMO Partnerships: Easing The Pain, Maximizing The Gain In Manufacturing

SPONSOR

PDA Week 2025 Embracing Change: Catalysts for Disruption: 06-11 APRIL 2025 | PALM SPRINGS | #PDAweek2025

Get ready for the event of the year! PDA Week 2025 is the premier annual homecoming event for the global pharma community. In today's dynamic industry landscape, PDA Week serves as the pharma community's anchor point for knowledge sharing, networking, and professional growth. Register Now

FEATURED EDITORIAL

Pain And Pleasure In Project Management Of CDMOs

Tony Sampognaro of Stoke Therapeutics, says, “We're having to rearrange and bolster the constellation of CDMOs we're working with." The nice thing is, Stoke has a comprehensive extended enterprise model. Nonetheless, an all-outsourced model “can add hidden complexity." Here's how to manage that.

Are CDMO Partnerships The Answer To Manufacturing Capacity Issues?

The current manufacturing strain is exacerbated by factors such as the intensity of scaling up fill-finish and specialized manufacture of drug delivery devices. How can partnering with a CDMO help?

INDUSTRY INSIGHTS

Scaling Up A Revolutionary Amorphous Solid Dispersion Platform

Process parameter and quality attribute relationships, including those for typical pre- and post-ASD unit operations, will be explored in the context of real-world examples.

Transforming A Liquid Protein Solution Into A Solid Oral Dosage Form

Unlocking the potential of oral protein therapeutics requires innovative formulation and manufacturing strategies to overcome stability, absorption, and bioavailability challenges.

Ensuring The Efficacy Of Probiotic Products

Without proper handling and packaging, the efficacy of probiotics can be compromised at any point in the packaging, storage, and transportation process, impacting shelf life and effectiveness.

The Flux Performance Of Nanoformed And Untreated PRX Solid Suspensions

Explore the application of in vitro flux assays to nanoparticles, with data on how the in vitro permeability apparatus can characterize the membrane flux performance of an API formulated as a nanosuspension.

Providing Packing And Blinding Solutions For An Innovative Drug Start-Up

Discover how a CDMO with integrated services enabled a botanical drug start-up to commence its Phase 1 clinical trial, paving the way for further advancement of its innovative botanical drug.

Pharmaceutical Spray Drying: Sustainable Commercial Best Practices

Learn more about defining the spray drying process with an emphasis on specific enhancements to accommodate scale-up to commercial scale equipment of challenging applications or molecules.

SOLUTIONS

Molecule To Cure. Fast.

Everything we do for our customers is driven by an unswerving belief that ideas need to become solutions, molecules need to become cures, fast. Because humanity needs solutions, fast.

Flexible Manufacturing Solutions, Services To Meet Evolving Industry Needs

Review our full range of support services to streamline manufacturing processes through to the commercialization of aseptic and lyophilized products.

Capacity Update January 2025: Small Molecule

With cutting-edge capabilities and client-focused solutions, we support your drug development journey from concept to commercialization, bringing transformative therapies to patients with speed and quality.

OUTSOURCED PHARMA CAPACITY UPDATE

Find Your New CDMO At Outsourced Pharma Capacity Update

CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capacities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs.

Connect With Outsourced Pharma: